Exagen Inc.
XGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $147,179 | $66,621 | $74,632 |
| - Cash | $35,652 | $30,033 | $11,194 | $22,036 |
| + Debt | $25,161 | $2,894 | $5,031 | $23,363 |
| Enterprise Value | – | $120,040 | $60,458 | $75,959 |
| Revenue | $17,244 | $17,202 | $15,498 | $13,655 |
| % Growth | 0.2% | 11% | 13.5% | – |
| Gross Profit | $10,075 | $10,395 | $9,123 | $8,477 |
| % Margin | 58.4% | 60.4% | 58.9% | 62.1% |
| EBITDA | -$5,304 | -$2,812 | -$2,767 | -$2,771 |
| % Margin | -30.8% | -16.3% | -17.9% | -20.3% |
| Net Income | -$7,087 | -$4,439 | -$3,752 | -$3,761 |
| % Margin | -41.1% | -25.8% | -24.2% | -27.5% |
| EPS Diluted | -0.31 | -0.21 | -0.2 | -0.2 |
| % Growth | -47.6% | -5% | 0% | – |
| Operating Cash Flow | $2,944 | -$2,885 | -$10,671 | $363 |
| Capital Expenditures | -$275 | -$209 | -$113 | -$146 |
| Free Cash Flow | $2,669 | -$3,094 | -$10,784 | $217 |